<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Luyang Yu</submitter><species>Homo Sapiens</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0006849000</full_dataset_link><submitter_email>luyangyu@zju.edu.cn</submitter_email><submitter_affiliation>Zhejiang University</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol><pubmed_abstract>Perinatal stem cells have prominent applications in cell therapy and regenerative medicine. Among them, human Wharton's jelly mesenchymal stem/stromal cells (hWJMSCs) and human amniotic epithelial stem cells (hAESCs) have been widely used. However, the distinction in the therapeutic potential of hWJMSCs and hAESCs is poorly understood. In this study, we reported the phenotypic differences between these two distinct cell types and provided the first systematic comparison of their therapeutic potential in terms of immunomodulation, extracellular matrix (ECM) remodelling, angiogenesis and antioxidative stress using proteomics. The results revealed that the two cell types presented different protein expression profiles and were both promising candidates for cell therapy. Both types of cells demonstrated angiogenic and antifibrotic potential, whereas hAESCs presented superior immunological tolerance and antioxidant properties, which were supported by a series of relevant in vitro assays. Our study provides clues for the selection of appropriate cell types for diverse indications in cell therapy, which contributes to the advancement of their clinical translation and application.</pubmed_abstract><pubmed_title>Proteomic analysis of human Wharton's jelly mesenchymal stem/stromal cells and human amniotic epithelial stem cells: a comparison of therapeutic potential.</pubmed_title><pubmed_authors>Ge Zhen Z, Qiu Chen C, Zhou Jiayi J, Yang Zhuoheng Z, Jiang Tuoying T, Yuan Weixin W, Yu Luyang L, Li Jinying J</pubmed_authors><name_synonyms>Whartons Jelly, Mother Cell, Therapy, Colony Forming Unit, human being, Man (Taxonomy), Wharton's, Stromal, axis, Stem, Modern, Progenitor Cells, Colony-Forming Units, Progenitor Cell, Mother, stalk, Colony Forming Units, Treatments., Scanning Transmission, human, culm, Cell, Wharton's Jelly, Human, umbilical cord mesenchyme, Electron Microscopy, Colony-Forming Unit, Homo sapiens, primary axis, epithelial, Stem Cell, Therapeutic, Stromal Cell, Modern Man, Cells, proteomic analysis, STEM, Mother Cells, Therapies, Scanning Transmission Electron Microscopy, Wharton, Treatment, primary stem, Man, Progenitor, Jelly, Wharton's jelly, epitheliocyte</name_synonyms><pubmed_abstract_synonyms>DNA Oxidative, protein translation, Anti Oxidants, Activity, selection process, Nitrative Stress, protein, Damage, dmTAF[[II]]230, protein synthesis., Techniques, Oxidative DNA, Oxidative, Nitro-Oxidative Stress, Mother Cells, Scanning Transmission Electron Microscopy, Nitro-Oxidative Stresses, Extracellular Matrices, Oxidative Injury, protein aggregate, primary stem, DNA Damage, Whartons Jelly, Anti Oxidant, Oxidative Injuries, Man (Taxonomy), TFIID TAF250, cel, Tissue, Oxidative Cleavage, Oxidative DNA Damages, Anti-oxidative, Oxidative Stress Injuries, Oxidative Stresses, GPIa*, Immunomodulations, Antioxidant, Anti-Oxidant Effect, Medicine, Therapies, Wharton, Medicines, Therapy, protein anabolism, dTAF[[II]]230, protein biosynthetic process, Modern, Antioxidants, TAF200, Endogenous, Test, TAFII-250, TAF250/230, Anti-Oxidants, Electron Microscopy, TAFII250, Colony-Forming Unit, Stem Cell, epithelial, Oxidative and Nitrosative Stress, protein formation, DNA Oxidative Damages, Wharton's jelly, Mother Cell, antioxidants, In Vitro, Stem, Tests, Colony Forming Units, CG17603, Immunomodulatory Therapies, TAF[[II]], Treatments, human, Nitro-Oxidative, Endogenous Antioxidants, primary axis, Taf250, SR3-5, Cells, STEM, Regenerative Medicines, Oxidative Stress Injury, DNA, TAF230, Oxidative Damage, Oxidative Stress, d230, human being, Wharton's, In Vitro as Topic, Testings, Stromal, Peptidomics, Antioxidative, Endogenous Antioxidant, Colony-Forming Units, antoxidant, Progenitor Cell, Matrix, Antioxidative Stress, Gene, antioxydant, stalk, dTAFII250, Angiogeneses, Matrices, protein-containing complex, EfW1, Immunomodulatory, Wharton's Jelly, Human, Stresses, Regenerative, umbilical cord mesenchyme, In Vitro Testing, Oxidative Nitrative, Homo sapiens, dmTAF1, Stress Injury, Cell Therapy, Taf230, Stromal Cell, Anti-Oxidant, Gene Products, Oxidative Cleavages, Anti-Oxidant Effects, Progenitor, Man, Technique, Oxidative Damages, In Vitro Tests, TAF250, study, Taf200, matrisome, In, Injury, dTAF[[II]]250, cell, Mother, Taf1p, culm, dTAF250, Anti oxidative Stress, Oxidative DNA Damage, Antioxidative Stresses, Extracellular, Antioxidant Activity, ECM, blood vessel formation from pre-existing blood vessels, TAF, Colony Forming Unit, TAF[[II]]250, axis, protein complex, Progenitor Cells, Proteins, l(3)84Ab, Scanning Transmission, BG:DS00004.13, Anti-oxidative Stresses, Cell, Anti Oxidant Effect, EMILIN4, Testing, dTAF230, Oxidative Nitrative Stress, Cell and Tissue Based Therapy, Tissue Therapy, In Vitro Test, native protein, p230, Oxidative Nitrative Stresses, Antioxidant Effect, Protein, In Vitro Testings, TAF[[II]]250/230, TFIID, protein biosynthesis, Immunomodulatory Therapy, Vitro Testing, epitheliocyte, Taf[[II]]250, Anti Oxidant Effects, TAF[[II]]230, Anti-oxidative Stress, DNA Oxidative Damage, TAF[II]250, Cleavage, Protein Gene Products, Gene Proteins, Antioxidant Effects, DmelCG17603, Therapeutic, Modern Man, Stress, In Vitro Technique, Treatment, MMRN, Nitro Oxidative Stress, Jelly, TAF1</pubmed_abstract_synonyms><pubmed_title_synonyms>Whartons Jelly, Mother Cell, Therapy, Colony Forming Unit, human being, Man (Taxonomy), Wharton's, Stromal, axis, Stem, Modern, Progenitor Cells, Colony-Forming Units, Progenitor Cell, Mother, stalk, Colony Forming Units, Treatments., Scanning Transmission, human, culm, Cell, Wharton's Jelly, Human, umbilical cord mesenchyme, Electron Microscopy, Colony-Forming Unit, Homo sapiens, primary axis, epithelial, Stem Cell, Therapeutic, Stromal Cell, Modern Man, Cells, proteomic analysis, STEM, Mother Cells, Therapies, Scanning Transmission Electron Microscopy, Wharton, Treatment, primary stem, Man, Progenitor, Jelly, Wharton's jelly, epitheliocyte</pubmed_title_synonyms><description_synonyms>DNA Oxidative, protein translation, Anti Oxidants, Ghrfr, Oxidative Stress, TNF-alpha, human being, Procedures, Activity, Wharton's, Stromal, Peptidomics, Antioxidative, Endogenous Antioxidant, Colony-Forming Units, antoxidant, Progenitor Cell, Matrix, Antioxidative Stress, Nitrative Stress, Gene, antioxydant, stalk, Angiogeneses, protein, Matrices, protein-containing complex, Immunomodulatory, Damage, Wharton's Jelly, Human, Stresses, Regenerative, umbilical cord mesenchyme, protein synthesis., TNF-a, Techniques, Oxidative Nitrative, Homo sapiens, Oxidative DNA, Oxidative, Stress Injury, Cell Therapy, Method, Stromal Cell, Anti-Oxidant, Nitro-Oxidative Stress, Mother Cells, Studies, Gene Products, Oxidative Cleavages, Immunosuppression (Physiology), Scanning Transmission Electron Microscopy, Nitro-Oxidative Stresses, Extracellular Matrices, Anti-Oxidant Effects, Oxidative Injury, protein aggregate, primary stem, xtnf-alpha, Progenitor, Man, Technique, DNA Damage, Oxidative Damages, Whartons Jelly, study, Anti Oxidant, Oxidative Injuries, matrisome, Injury, Man (Taxonomy), Tissue, Oxidative Cleavage, Mother, CG6794, procedures, Oxidative DNA Damages, culm, Anti-oxidative, DIF, Study, Oxidative Stress Injuries, Oxidative Stresses, Immune, GPIa*, Methodological Studies, Anti oxidative Stress, Immunomodulations, Oxidative DNA Damage, Antioxidative Stresses, Immunosuppressions (Physiology), Antioxidant, Extracellular, Antioxidant Activity, ECM, blood vessel formation from pre-existing blood vessels, Anti-Oxidant Effect, Medicine, TNFSF2, Therapies, Wharton, Medicines, dif, Therapy, tnfa, protein anabolism, Colony Forming Unit, 6794, protein biosynthetic process, axis, xtnf, protein complex, Progenitor Cells, Modern, Proteins, Antioxidants, TNFA, Endogenous, lit, Scanning Transmission, Procedure, Anti-oxidative Stresses, Cell, Anti-Oxidants, Anti Oxidant Effect, EMILIN4, Electron Microscopy, tnfsf2, Oxidative Nitrative Stress, Cell and Tissue Based Therapy, Tissue Therapy, Colony-Forming Unit, native protein, Stem Cell, epithelial, Oxidative and Nitrosative Stress, Oxidative Nitrative Stresses, Antioxidant Effect, Protein, tnf-alpha, protein formation, protein biosynthesis, Immunomodulatory Therapy, DNA Oxidative Damages, techniques, neurotrophin receptor signaling pathway, Wharton's jelly, epitheliocyte, little, Mother Cell, Anti Oxidant Effects, antioxidants, Anti-oxidative Stress, DNA Oxidative Damage, Stem, Colony Forming Units, TNFalpha, Methodological, Cleavage, Immunomodulatory Therapies, Methodological Study, Treatments, cell_type, human, Nitro-Oxidative, Protein Gene Products, Gene Proteins, Antioxidant Effects, DmelCG6794, Endogenous Antioxidants, Tolerance, primary axis, Therapeutic, Modern Man, Cells, Stress, STEM, Regenerative Medicines, Tnfa, Treatment, Oxidative Stress Injury, DNA, MMRN, Nitro Oxidative Stress, Jelly, Tnfsf1a, methodology, Oxidative Damage</description_synonyms></additional><is_claimable>false</is_claimable><name>Proteomic analysis of human Wharton's jelly mesenchymal stem/stromal cells and human amniotic epithelial stem cells: a comparison of therapeutic potential</name><description>Background: Perinatal stem cells have prominent applications in cell therapy and regenerative medicine. Among them, human Wharton's jelly mesenchymal stem/stromal cells (hWJMSCs) and human amniotic epithelial stem cells (hAESCs) are widely used. However, little is known about the dif-ferences in the therapeutic potential of hWJMSCs and hAESCs.  Methods: In this study, we reported the phenotypic differences between the two cells and provided the first systematic comparison of their therapeutic potential in terms of immunomodulation, extracellular matrix (ECM) remod-eling, angiogenesis and anti-oxidative stress by means of proteomics.  Results: The results showed that the two cells had different protein expression profiles and were both promising candidates for cell therapy. hWJMSCs had a stronger angiogenic potential, while hAESCs had advantages in terms of immune tolerance and antioxidant properties. Notably, hAESCs were found to be enriched in the neurotrophin signaling pathway.  Conclusions: Our study provides clues on the choice of cell type in cell therapy for different indications, which will be beneficial in advancing their further clinical translation and application.</description><dates><publication>Wed Aug 02 00:00:00 GMT+01:00 2023</publication></dates><accession>PXD044276</accession><cross_references><TAXONOMY>9606</TAXONOMY><pubmed>39543366</pubmed></cross_references></HashMap>